GL1X · GenesisL1 explorer

Research workbench

Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase in complex with nevirapine

Analyse Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1FKP
Type
protein
Length
950 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 rt, a-chain; HIV-1 rt, B-chain
EC
2.7.7.49
UniProt
P04585
Ligands
NVP
Pockets
17 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 rt, a-chain (EC 2.7.7.49)protein54231% helix, 24% strandP04585
BHIV-1 rt, B-chain (EC 2.7.7.49)protein40836% helix, 20% strandP04585

Ligands and binding sites

  • NVP · 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18280.780.8184NVP
24410.760.8543empty
3830.610.8921empty
43860.610.7736empty
53690.590.7640empty

Interfaces

1 interface between chains.

  • A–B · 2630 Ų buried · 29 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 1FKP · Crystal structure of nnrti resistant K103N mutant HIV-1 reverse transcriptase in complex… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.